Michiel Coppens

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi request reprint A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation
    Michiel Coppens
    Department of Vascular Medicine F4 276, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Blood 108:2604-7. 2006
  2. ncbi request reprint Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations
    M Coppens
    Academic Medical Center, Department of Vascular Medicine, Amsterdam, The Netherlands
    J Thromb Haemost 5:1444-8. 2007
  3. ncbi request reprint Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Thromb Haemost 98:1040-4. 2007
  4. ncbi request reprint Recent advances in antidotes for direct oral anticoagulants: their arrival is imminent
    Mandy N Lauw
    Population Health Research Institute, Hamilton, Ontario, Canada Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands Electronic address
    Can J Cardiol 30:381-4. 2014
  5. pmc Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg
    Mandy N Lauw
    Department of Hematology, Academic Medical Center, F4 224, 1100 DD Amsterdam, The Netherlands
    Ann Hematol 91:103-7. 2012
  6. ncbi request reprint Sex, thrombosis and inherited thrombophilia
    Suzanne M Bleker
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Blood Rev 28:123-33. 2014
  7. doi request reprint New oral anticoagulants in elderly patients
    Stefano Barco
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Best Pract Res Clin Haematol 26:215-24. 2013
  8. doi request reprint New developments in parenteral anticoagulation for arterial and venous thromboembolism
    Nick van Es
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Best Pract Res Clin Haematol 26:203-13. 2013
  9. doi request reprint Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term
    Paulien G de Jong
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Br J Haematol 158:433-41. 2012
  10. ncbi request reprint Inherited thrombophilias
    Michiel Coppens
    Academic Medical Center, F4 276, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Obstet Gynecol Clin North Am 33:357-74. 2006

Collaborators

Detail Information

Publications12

  1. ncbi request reprint A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation
    Michiel Coppens
    Department of Vascular Medicine F4 276, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Blood 108:2604-7. 2006
    ....
  2. ncbi request reprint Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations
    M Coppens
    Academic Medical Center, Department of Vascular Medicine, Amsterdam, The Netherlands
    J Thromb Haemost 5:1444-8. 2007
    ..The factor V Leiden (FVL) and prothrombin 20210A (PTm) mutations are associated with single late pregnancy loss and recurrent early pregnancy loss. The prognosis after an initial loss in women with thrombophilia is uncertain...
  3. ncbi request reprint Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Thromb Haemost 98:1040-4. 2007
    ..Elevated FVIII:c may be a common risk factor for both clinical entities...
  4. ncbi request reprint Recent advances in antidotes for direct oral anticoagulants: their arrival is imminent
    Mandy N Lauw
    Population Health Research Institute, Hamilton, Ontario, Canada Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands Electronic address
    Can J Cardiol 30:381-4. 2014
    ....
  5. pmc Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg
    Mandy N Lauw
    Department of Hematology, Academic Medical Center, F4 224, 1100 DD Amsterdam, The Netherlands
    Ann Hematol 91:103-7. 2012
    ..Thus, in patients with non-splanchnic venous thrombosis, JAK2V617F appears not to be clinically relevant...
  6. ncbi request reprint Sex, thrombosis and inherited thrombophilia
    Suzanne M Bleker
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Blood Rev 28:123-33. 2014
    ..This review focuses on the differences in risk of VTE between men and women, hormonal risk factors for women, and how these interact with common types of hereditary thrombophilia. ..
  7. doi request reprint New oral anticoagulants in elderly patients
    Stefano Barco
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Best Pract Res Clin Haematol 26:215-24. 2013
    ..Results show that the favourable balance between risks and benefits of NOACs is preserved in the elderly population. ..
  8. doi request reprint New developments in parenteral anticoagulation for arterial and venous thromboembolism
    Nick van Es
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Best Pract Res Clin Haematol 26:203-13. 2013
    ..Still, promising new anticoagulants, some targeting less conventional targets in the coagulation system, have been developed and will undergo further clinical evaluation. ..
  9. doi request reprint Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term
    Paulien G de Jong
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Br J Haematol 158:433-41. 2012
    ..Extended treatment can be considered, based mainly on patient preference...
  10. ncbi request reprint Inherited thrombophilias
    Michiel Coppens
    Academic Medical Center, F4 276, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Obstet Gynecol Clin North Am 33:357-74. 2006
    ..For this group, well-designed placebo-controlled trials to assess the harm-benefit ratio are urgently needed...
  11. doi request reprint Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels
    Nienke Folkeringa
    Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    Thromb Haemost 100:38-44. 2008
    ..None of these concomitant defects showed interaction with high TAFI levels. High TAFI levels were not associated with an increased risk of venous and arterial thromboembolism in thrombophilic families...
  12. ncbi request reprint The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects
    Willem M Lijfering
    Division of Haemostasis, Thrombosis and Rheology, Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    Thromb Haemost 98:457-63. 2007
    ..Concomitant thrombophilic defects are probably main determinants on the risk of venous thrombosis, rather than hyperhomocysteinaemia itself...